Recordati Industria Chimica e Farmaceutica S.p.A. revenue breakdown overview

Recordati Industria Chimica e Farmaceutica S.p.A. revenue for the last year amounted to 2.30 B USD, the most of which — 1.51 B USD — came from its highest performing source at the moment, Specialty & Primary Care, the year earlier bringing 1.35 B USD. The greatest contribution to the revenue figure was made by Europe — last year it brought Recordati Industria Chimica e Farmaceutica S.p.A. 1.30 B USD, and the year before that — 1.16 B USD.